Sarepta Therapeutics (SRPT) FCF Margin (QoQ) (2010 - 2026)

Sarepta Therapeutics (SRPT) FCF Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Sarepta Therapeutics 1.66 Bn 1.25 Bn 622.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,683.00
Dec 31, 2025 3,821.00
Sep 30, 2025 -4,696.00
Jun 30, 2025 50,788.00
Mar 31, 2025 -47,851.00
Dec 31, 2024 3,131.00
Sep 30, 2024 -1,919.00
Jun 30, 2024 6,248.00
Mar 31, 2024 -5,956.00
Dec 31, 2023 3,984.00
Sep 30, 2023 697.00
Jun 30, 2023 4,091.00
Mar 31, 2023 -8,297.00
Dec 31, 2022 2,020.00
Sep 30, 2022 414.00
Jun 30, 2022 2,060.00
Mar 31, 2022 -3,889.00
Dec 31, 2021 57,613.00
Sep 30, 2021 -52,367.00
Jun 30, 2021 6,704.00